Mineralys Therapeutics

Mineralys Therapeutics Receives FDA Clearance for Phase 2 Trial of Lorundrostat in Treating Sleep Apnea and Hypertension

RADNOR, PA — Mineralys Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for a Phase 2 clinical trial …

Mineralys Therapeutics Receives FDA Clearance for Phase 2 Trial of Lorundrostat in Treating Sleep Apnea and Hypertension Read More

U.S. Food and Drug Administration (FDA)

Your Health at Stake: FDA Sounds the Alarm on Tainted Oysters, Shocking PFAS Packaging Risks, and Bold Medical Breakthroughs!

WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has announced several critical developments spanning food safety, medical device oversight, and healthcare innovation. These updates reflect the agency’s ongoing …

Your Health at Stake: FDA Sounds the Alarm on Tainted Oysters, Shocking PFAS Packaging Risks, and Bold Medical Breakthroughs! Read More

Cosmetics makeup brushes and powder dust

FDA Takes Bold Stand to Protect Consumers with Standardized Asbestos Testing in Talc-Based Cosmetics

WASHINGTON, D.C. — The U.S. Food and Drug Administration isn’t just making a suggestion—it’s drawing a line in the sand. Last week, the FDA proposed a hard-hitting rule to establish standardized …

FDA Takes Bold Stand to Protect Consumers with Standardized Asbestos Testing in Talc-Based Cosmetics Read More
U.S. Food and Drug Administration

FDA Approves First Generic Liraglutide Injection, Ushering in a New Era for Type 2 Diabetes Treatment

WASHINGTON, D.C. — The fight against type 2 diabetes just reached a groundbreaking milestone. Last week, the U.S. Food and Drug Administration (FDA) approved the first generic version of liraglutide injection, …

FDA Approves First Generic Liraglutide Injection, Ushering in a New Era for Type 2 Diabetes Treatment Read More